Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Camden National Corporation is a banks-regional business based in the US. Camden National Corporation shares (CAC) are listed on the NASDAQ and all prices are listed in US Dollars. Camden National Corporation employs 620 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $44.86 |
|---|---|
| 52-week range | $41.48 - $51.72 |
| 50-day moving average | $44.32 |
| 200-day moving average | $47.39 |
| Wall St. target price | $50.00 |
| PE ratio | 10.129 |
| Dividend yield | $1.52 (3.57%) |
| Earnings per share (TTM) | $4.42 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $44.86 from 2022-07-05
| 1 week (2022-06-30) | 1.84% |
|---|---|
| 1 month (2022-06-07) | -0.84% |
| 3 months (2022-04-07) | -4.15% |
| 6 months (2022-01-07) | -13.11% |
| 1 year (2021-07-07) | -2.58% |
|---|---|
| 2 years (2020-07-07) | 37.69% |
| 3 years (2019-07-05) | 45.3 |
| 5 years (2017-07-07) | 1.04% |
Valuing Camden National Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Camden National Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Camden National Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Camden National Corporation shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $188.1 million |
|---|---|
| Operating margin TTM | 45.42% |
| Gross profit TTM | $190.4 million |
| Return on assets TTM | 1.26% |
| Return on equity TTM | 13.02% |
| Profit margin | 35.13% |
| Book value | $32.72 |
| Market capitalisation | $656.2 million |
TTM: trailing 12 months
Dividend payout ratio: 35.29% of net profits
Recently Camden National Corporation has paid out, on average, around 35.29% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.57% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Camden National Corporation shareholders could enjoy a 3.57% return on their shares, in the form of dividend payments. In Camden National Corporation's case, that would currently equate to about $1.52 per share.
While Camden National Corporation's payout ratio might seem fairly standard, it's worth remembering that Camden National Corporation may be investing much of the rest of its net profits in future growth.
Camden National Corporation's most recent dividend payout was on 28 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 July 2022 (the "ex-dividend date").
Camden National Corporation's shares were split on a 3:2 basis on 2 October 2016. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Camden National Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Camden National Corporation shares which in turn could have impacted Camden National Corporation's share price.
Over the last 12 months, Camden National Corporation's shares have ranged in value from as little as $41.48 up to $51.7159. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Camden National Corporation's is 0.8426. This would suggest that Camden National Corporation's shares are less volatile than average (for this exchange).
Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system. It also offers non-owner-occupied commercial estate loans, owner-occupied commercial real estate loans, unsecured fully-guaranteed commercial loans backed by the U. S. small business administration, loans secured by one-to four-family properties, and consumer and home equity loans. In addition, the company provides brokerage and insurance services through its financial offerings consisting of college, retirement, estate planning, mutual funds, strategic asset management accounts, and variable and fixed annuities. Further, it offers a range of fiduciary and asset management, wealth management, investment management, financial planning, and trustee services.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.